Shailendra Lakhanpal
Overview
Explore the profile of Shailendra Lakhanpal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rocque G, Blum J, Ji Y, Pluard T, Migas J, Lakhanpal S, et al.
Breast Cancer Res Treat
. 2024 Nov;
209(3):613-627.
PMID: 39581892
Purpose: To evaluate patient-reported health-related quality-of-life (QoL) in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced/metastatic breast cancer (ABC) treated with palbociclib in the longitudinal real-world study,...
2.
Karuturi M, Cappelleri J, Blum J, Patel K, Telivala B, McCune S, et al.
J Geriatr Oncol
. 2023 Dec;
15(1):101670.
PMID: 38061288
Introduction: Limited data are available on the effects of treatment for advanced breast cancer (ABC) in older patients because this population has limited enrollment in clinical trials. Data generated from...
3.
Blum J, DiCristo C, Gordon D, Karuturi M, Oubre D, Jepsen E, et al.
Breast Cancer Res Treat
. 2023 Oct;
203(3):463-475.
PMID: 37903899
Purpose: Data on treatments for male breast cancer patients are limited owing to rarity and underrepresentation in clinical trials. The real-world POLARIS study gathers data on palbociclib use for the...
4.
Flowers C, Brown J, Rosenthal H, Stock W, Katzen H, Cohen J, et al.
Clin Lymphoma Myeloma Leuk
. 2015 Sep;
15(11):694-8.
PMID: 26385641
Background: Alemtuzumab is effective in fludarabine-refractory patients with chronic lymphocytic leukemia. We performed a phase 2 study of alemtuzumab in combination with fludarabine in patients with relapsed disease. Patients And...